Circulating Y-RNAs as New Players in Parkinson Disease and Their Associations with Clinical Measures
Authors:
- Violeta BelickienėVBVioleta Belickienė
- Paulina VaitkienėPVPaulina Vaitkienė
- Daina SkiriutėDSDaina Skiriutė
- Aistė PranckevičienėAPAistė Pranckevičienė
- Andrius RadžiūnasARAndrius Radžiūnas
- Greta ŽvinakytėGŽGreta Žvinakytė
- Zbigniev BalionZBZbigniev Balion
- Chitra VenugopalCVChitra Venugopal
- Sheila K. SinghSheila K. Singh
- Giedrius SteponaitisGSGiedrius Steponaitis
Open Access
- 13 November 2026
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (11) , 1212
Abstract
Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuron loss, and current therapies provide only symptomatic relief. Extracellular vesicles (EVs) have emerged as potential mediators of disease-modifying effects through the transfer of proteins, lipids, and non-coding RNAs. Y-RNAs, a conserved yet understudied class of small non-coding RNAs enriched in EVs, are implicated in fundamental cellular processes such as DNA replication, RNA stability, RNA quality control, and stress-response pathways, and may reflect disease-related cellular states, particularly given that some Y-RNA species are primate-specific. This study aimed to characterize Y-RNA expression in human neural cell models, determine how intracellular levels relate to EV-enriched extracellular profiles, and assess whether serum EV-enriched Y-RNAs show PD-associated alterations with diagnostic relevance and associations with clinical status. Methods: Human neural stem cells and malignant neural cell models were profiled for intracellular Y-RNA expression and EV-enriched extracellular Y-RNAs using EV-enriched RNA preparations. Serum samples from individuals with PD and healthy controls were analyzed to quantify circulating EV-enriched Y-RNAs. Relative Y-RNA abundance and pairwise relative Y-RNA expression measures were compared across cellular models, EV-enriched fractions, and clinical samples to identify disease-related patterns. Results: Y-RNAs displayed distinct relative expression patterns across neural cell models. EV-enriched profiles differed markedly from intracellular abundance, with consistent enrichment of RNY4 and depletion of RNY1 in EV-enriched fractions. These intracellular–extracellular differences were preserved in vesicles released under baseline conditions. In serum EV-enriched fractions, PD was associated with a specific Y-RNA signature: RNY3 related to disease presence, whereas RNY5 correlated with disease duration and severity. Pairwise relative Y-RNA expression measures also provided biologically informative signals both in cell models and patient samples. Conclusions: EV-enriched Y-RNA profiles diverge from intracellular patterns and h exploratory clinical relevance in PD, supporting their potential as markers of disease severity and contributors to disease-related molecular communication.Keywords
Funding Information
- Research Council of Lithuania (S-MIP-23-99)
This publication has 54 references indexed in Scilit:
- Development of an Effective Isolation Method for Plasma Extracellular Vesicles Excluding Lipoproteins by Precipitation With Polyethylene GlycolJournal of Extracellular Biology, 2025
- Expression Levels of Plasma YRNAs in Colorectal Cancer as a Potential Noninvasive BiomarkerJournal of Gastrointestinal Cancer, 2025
- From stem cells to extracellular vesicles: a new horizon in tissue engineering and regenerative medicineCytotechnology, 2024
- MicroRNA expression in extracellular vesicles as a novel blood‐based biomarker for Alzheimer's diseaseAlzheimer's & Dementia, 2023
- Y RNAs: Biogenesis, Function and Implications for the Cardiovascular System2020
- Transmigration of Tetraspanin 2 (Tspan2) siRNA Via Microglia Derived Exosomes across the Blood Brain Barrier Modifies the Production of Immune Mediators by Microglia CellsJournal of Neuroimmune Pharmacology, 2019
- Immune stimuli shape the small non-coding transcriptome of extracellular vesicles released by dendritic cellsCellular and Molecular Life Sciences, 2018
- Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing resultsMovement Disorders, 2008
- Wechsler Adult Intelligence Scale-III2001
- The development and validation of a short measure of functioning and well being for individuals with Parkinson's diseaseQuality of Life Research, 1995